Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
Clinical trial NCT05745532 · RECRUITING
Trial details
- NCT number
- NCT05745532
- Sponsor
- Shenzhen Hemogen
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2025-05-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.